Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency. | J Ovarian Res | 2023 | 37848988 | PubTator, text mining | PubMed |
Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-boxFBXO11 -mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma. | Clin Transl Med | 2023 | 37837399 | PubTator, text mining | PubMed |
| A noncanonical function of SKP1 regulates the switch between autophagy and unconventional secretion. | Sci Adv | 2023 | 37831778 | PubTator, text mining | PubMed |
| FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing. | Adv Sci (Weinh) | 2023 | 37822160 | PubTator, text mining | PubMed |
| The hybrid RAVE complex plays V-ATPase-dependent and -independent pathobiological roles in Cryptococcus neoformans. | PLoS Pathog | 2023 | 37812645 | PubTator, text mining | PubMed |
| Proliferation-associated 2G4 P48 is stabilized by malignant T-cell amplified sequence 1 and promotes the proliferation of head and neck squamous cell carcinoma. | J Dent Sci | 2023 | 37799877 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases in bone homeostasis and related diseases. | Acta Pharm Sin B | 2023 | 37799379 | PubTator, text mining | PubMed |
| The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer. | Redox Biol | 2023 | 37783059 | PubTator, text mining | PubMed |
| Synergy between a cytoplasmic vWFA/VIT protein and a WD40-repeat F-box protein controls development in Dictyostelium. | Front Cell Dev Biol | 2023 | 37779900 | PubTator, text mining | PubMed |
| Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases. | Exp Mol Med | 2023 | 37779139 | PubTator, text mining | PubMed |
| KDM2B regulates inflammation and oxidative stress of sepsis via targeting NF-κB and AP-1 pathways. | Immun Inflamm Dis | 2023 | 37773725 | PubTator, text mining | PubMed |
| MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages. | mBio | 2023 | 37773002 | PubTator, text mining | PubMed |
| HCMV UL8 interaction with β-catenin and DVL2 regulates viral reactivation in CD34+ hematopoietic progenitor cells. | J Virol | 2023 | 37772824 | PubTator, text mining | PubMed |
| Targeting cullin neddylation for cancer and fibrotic diseases. | Theranostics | 2023 | 37771770 | PubTator, text mining | PubMed |
| NLRP6 potentiates PI3K/AKT signalling by promoting autophagic degradation of p85α to drive tumorigenesis. | Nat Commun | 2023 | 37770465 | PubTator, text mining | PubMed |
| Ubiquitin-Dependent and Independent Proteasomal Degradation in Host-Pathogen Interactions. | Molecules | 2023 | 37764516 | PubTator, text mining | PubMed |
| RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy. | Biomedicines | 2023 | 37760968 | PubTator, text mining | PubMed |
| Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors. | Front Genet | 2023 | 37745860 | PubTator, text mining | PubMed |
| The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation. | Nucleic Acids Res | 2023 | 37739411 | PubTator, text mining | PubMed |
| FBXW2 suppresses breast tumorigenesis by targeting AKT-Moesin-SKP2 axis. | Cell Death Dis | 2023 | 37736741 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=14